DJIA 16,495.50 -6.15 -0.04%
NASDAQ 4,145.44 18.48 0.45%
S&P 500 1,877.17 1.78 0.09%
market minute promo

Micromet, Inc.

NASDAQ: MITI

0.00 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

MITI $0.00 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.69

Sector

Healthcare

Industry

Biotechnology

Micromet, Inc. (MITI) Description

Website:

News & Commentary Rss Feed

Judge Declines To Block Amgen Purchase Of Micromet -AP

Micromet Shareholder Group Asks Judge To Delay Purchase By Amgen -AP

Amgen a Step Closer to Micromet - Analyst Blog

Make Money in Buyback Achievers the Easy Way

This fund sports a solid track record.

Amgen Upped to Outperform - Analyst Blog

Has Amgen Become the Perfect Stock?

Finding companies that have all the right stuff can produce winners.

The Week's Top Stock Gainers

It was a relatively lackluster week for stocks, but some managed to post some serious gains.

2 Biotech Acquisitions in 1 Day! Let's Throw a Party

Amgen and Celgene pull the trigger. Don't drop the keg.

UPDATE: Amgen 4Q Profit Falls 9% On Tax Impacts, Charges

Amgen, Celgene, Roche Deals Signal M&A Frenzy for Drug Companies

Cancer, hepatitis and personalized medicine are the focus of recently announced takeovers. More M&A transactions are likely.

See More MITI News...

MITI's Top Competitors

MITI $0.00 (0.00%)
Current stock: MITI
AMGN $114.38 (0.94%)
Current stock: AMGN
GILD $73.96 (0.14%)
Current stock: GILD
BIIB $294.75 (-3.91%)
Current stock: BIIB